Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Ultragenyx Pharmaceutical (RARE) Shares Issued: 2016-2024

Historic Shares Issued for Ultragenyx Pharmaceutical (RARE) over the last 5 years, with Jun 2024 value amounting to $381.0 million.

  • Ultragenyx Pharmaceutical's Shares Issued was N/A to $381.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $390.1 million, marking a year-over-year change of. This contributed to the annual value of $11.3 million for FY2024, which is 33.78% up from last year.
  • As of Q2 2024, Ultragenyx Pharmaceutical's Shares Issued stood at $381.0 million, which was up 18,940.48% from $2.0 million recorded in Q4 2022.
  • Ultragenyx Pharmaceutical's Shares Issued's 5-year high stood at $381.0 million during Q2 2024, with a 5-year trough of $380,000 in Q1 2020.
  • Over the past 2 years, Ultragenyx Pharmaceutical's median Shares Issued value was $2.0 million (recorded in 2022), while the average stood at $78.4 million.
  • As far as peak fluctuations go, Ultragenyx Pharmaceutical's Shares Issued plummeted by 99.88% in 2020, and later spiked by 3,258.16% in 2021.
  • Quarterly analysis of 4 years shows Ultragenyx Pharmaceutical's Shares Issued stood at $79.8 million in 2020, then tumbled by 91.32% to $6.9 million in 2021, then plummeted by 71.10% to $2.0 million in 2022, then reached $381.0 million in 2024.
  • Its Shares Issued stands at $381.0 million for Q2 2024, versus $2.0 million for Q4 2022 and $1.1 million for Q3 2022.